Asia Pacific enteral nutrition market will grow by 10.3% annually with a total addressable market cap of $44.18 billion over 2021-2030 owing to the increasing incidence of malnutrition, rising number of patients suffering with chronic diseases, and surge in adoption of enteral nutrition over parenteral nutrition due to lower cost and complications of enteral nutrition.
Highlighted with 70 tables and 56 figures, this 139-page report 鈥淎sia Pacific Enteral Nutrition 麻豆原创 2020-2030 by Nutrient, Application, Category, Product Form, End User, Distribution Channel, and Country: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire Asia Pacific enteral nutrition market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year (Year 2020 is not appropriate for research base due to the outbreak of COVID-19).
In-depth qualitative analyses include identification and investigation of the following aspects:
鈥� 麻豆原创 Structure
鈥� Growth Drivers
鈥� Restraints and Challenges
鈥� Emerging Product Trends & 麻豆原创 Opportunities
鈥� Porter鈥檚 Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific enteral nutrition market in every aspect of the classification from perspectives of Nutrient, Application, Category, Product Form, End User, Distribution Channel, and Country.
Based on Nutrient, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
鈥� Protein Based Nutrition
o Standard Protein Diet
o High Protein Supplement
o Protein for Diabetic Patients
o Other Protein-based Nutitions
鈥� Carbohydrates Based Nutrition
鈥� Fat Based Nutrition
鈥� Vitamin Based Nutrition
鈥� Other Nutrition Types
Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
鈥� Critical Care
鈥� Diabetes
鈥� Neurology
鈥� Oncology
鈥� Other Applications
Based on Category, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
鈥� Enteral Nutrition for Chronic Illness
鈥� Enteral Nutrition with Standard Formula
Based on Product Form, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
鈥� Liquid Enteral Nutrition
鈥� Powder Enteral Nutrition
Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
鈥� Pediatric
鈥� Adults
鈥� Geriatric
Based on Distribution Channel, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
鈥� Distribution by Hospitals
鈥� Distribution by Retail Pharmacies
鈥� Distribution by Online Pharmacies
Geographically, the following national/local markets are fully investigated:
鈥� Japan
鈥� China
鈥� South Korea
鈥� Australia
鈥� India
鈥� Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2019-2030. The breakdown of key national markets by Nutrient, Application, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Key Players (this may not be a complete list and extra companies can be added upon request):
Abbott Laboratories
B. Braun Melsungen AG
Baxter International, Inc.
Danone S.A.
Fresenius Kabi AG
Asia Pacific Health Products, Inc.
Hormel Foods Corporation
Meiji Holdings Co., Ltd.
Nestle S.A.
Reckitt Benckiser (Mead Johnson & Company LLC)
Victus, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 8
1.1 Industry Definition and Research Scope 8
1.1.1 Industry Definition 8
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of 麻豆原创 Research Methodology 12
1.2.2 麻豆原创 Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 15
1.2.6 麻豆原创 Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 麻豆原创 Overview and Dynamics 21
2.1 麻豆原创 Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the 麻豆原创 24
2.2 Major Growth Drivers 26
2.3 麻豆原创 Restraints and Challenges 29
2.4 Emerging Opportunities and 麻豆原创 Trends 32
2.5 Porter鈥檚 Fiver Forces Analysis 36
3 Segmentation of Asia Pacific 麻豆原创 by Nutrient 40
3.1 麻豆原创 Overview by Nutrient 40
3.2 Protein Based Nutrition 42
3.2.1 Standard Protein Diet 44
3.2.2 High Protein Supplement 45
3.2.3 Protein for Diabetic Patients 46
3.2.4 Other Protein-based Nutitions 47
3.3 Carbohydrates Based Nutrition 48
3.4 Fat Based Nutrition 49
3.5 Vitamin Based Nutrition 50
3.6 Other Nutrition Types 51
4 Segmentation of Asia Pacific 麻豆原创 by Application 52
4.1 麻豆原创 Overview by Application 52
4.2 Critical Care 54
4.3 Diabetes 55
4.4 Neurology 56
4.5 Oncology 57
4.6 Other Applications 58
5 Segmentation of Asia Pacific 麻豆原创 by Category 59
5.1 麻豆原创 Overview by Category 59
5.2 Enteral Nutrition for Chronic Illness 61
5.3 Enteral Nutrition with Standard Formula 62
6 Segmentation of Asia Pacific 麻豆原创 by Product Form 63
6.1 麻豆原创 Overview by Product Form 63
6.2 Liquid Enteral Nutrition 65
6.3 Powder Enteral Nutrition 66
7 Segmentation of Asia Pacific 麻豆原创 by End User 67
7.1 麻豆原创 Overview by End User 67
7.2 Pediatric 69
7.3 Adults 70
7.4 Geriatric 71
8 Segmentation of Asia Pacific 麻豆原创 by Distribution Channel 72
8.1 麻豆原创 Overview by Distribution Channel 72
8.2 Distribution by Hospitals 74
8.3 Distribution by Retail Pharmacies 75
8.4 Distribution by Online Pharmacies 76
9 Asia-Pacific 麻豆原创 2019-2030 by Country 77
9.1 Overview of Asia-Pacific 麻豆原创 77
9.2 Japan 80
9.3 China 84
9.4 Australia 87
9.5 India 89
9.6 South Korea 92
9.7 Rest of APAC Region 95
10 Competitive Landscape 97
10.1 Overview of Key Vendors 97
10.2 New Product Launch, Partnership, Investment, and M&A 100
10.3 Company Profiles 101
Abbott Laboratories 101
B. Braun Melsungen AG 103
Baxter International, Inc. 107
Danone S.A. 110
Fresenius Kabi AG 113
Global Health Products, Inc. 117
Hormel Foods Corporation 119
Meiji Holdings Co., Ltd. 121
Nestle S.A. 123
Reckitt Benckiser (Mead Johnson & Company LLC) 128
Victus, Inc. 131
11 Investing in Asia Pacific 麻豆原创: Risk Assessment and Management 133
11.1 Risk Evaluation of Asia Pacific 麻豆原创 133
11.2 Critical Success Factors (CSFs) 136
Related Reports and Products 139
Key Players (this may not be a complete list and extra companies can be added upon request):
Abbott Laboratories
B. Braun Melsungen AG
Baxter International, Inc.
Danone S.A.
Fresenius Kabi AG
Asia Pacific Health Products, Inc.
Hormel Foods Corporation
Meiji Holdings Co., Ltd.
Nestle S.A.
Reckitt Benckiser (Mead Johnson & Company LLC)
Victus, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
听
听
*If Applicable.
